Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Antimicrobial Agents and Chemotherapy
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Mechanisms of Resistance

Macrolide Antibiotic-Mediated Downregulation of MexAB-OprM Efflux Pump Expression in Pseudomonas aeruginosa

Makoto Sugimura, Hideaki Maseda, Hideaki Hanaki, Taiji Nakae
Makoto Sugimura
1Graduate School of Medical Science, Kitasato Institute University, 1-15-1 Kitasato, Sagamihara 228-8555, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hideaki Maseda
3Department of Biological Science and Technology, Faculty of Engineering, 2-1 Minamijyousanjima-cho, Tokushima 770-8605, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hideaki Hanaki
2Laboratory for Anti-infectious Drugs, Kitasato Institute University, Bldg. S-105, 1-15-1 Kitasato, Sagamihara 228-8555, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Taiji Nakae
2Laboratory for Anti-infectious Drugs, Kitasato Institute University, Bldg. S-105, 1-15-1 Kitasato, Sagamihara 228-8555, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: nakae-tj@insti.kitasato-u.ac.jp
DOI: 10.1128/AAC.00511-08
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

Macrolide antibiotics modulate the quorum-sensing system of Pseudomonas aeruginosa. We tested the effect of macrolide antibiotics on the cell density-dependent expression of the MexAB-OprM efflux pump and found that 1.0 μg/ml (MIC/6.25) of azithromycin suppressed the expression of MexAB-OprM by about 70%, with the result that the cells became two- to fourfold more susceptible to antibiotics such as aztreonam, tetracycline, carbenicillin, chloramphenicol, and novobiocin.

Long-term administration of a sub-MIC level of macrolide antibiotics has been used empirically to treat chronic respiratory infection caused by Pseudomonas aeruginosa (8, 13-15), though P. aeruginosa is intrinsically resistant to macrolides. The observation was interpreted to mean that macrolides perturb the production of cell density-dependent virulence factors via the quorum-sensing (Q-S) circuits (12, 27, 29, 30). The Q-S circuits in P. aeruginosa are composed of the las and rhl systems, which regulate the production of virulence factors, e.g., elastase and protease and biofilm formation (3, 9, 21, 30).

The P. aeruginosa genome carries several xenobiotic efflux pumps, and among them, MexAB-OprM plays a major role in antibiotic extrusion and resistance (5, 6, 19, 20, 24). The MexAB-OprM pump consists of the subunits MexB, OprM, and MexA (19, 20, 24), and their roles are the substrate-recognizing energy-transmitting subunit (7, 10, 18), the adapter protein (2, 6, 11) connecting MexB and OprM, and the antibiotics discharge duct protein (1, 19, 24), respectively. Thus, antibiotics are trapped by MexB, transferred to the OprM cavity, and eventually discharged to the external milieu with the aid of MexA (1, 2, 7, 11, 18). Expression of MexAB-OprM increases in a cell density-dependent manner, suggesting that expression may be linked to the Q-S circuit(s) (16, 22, 31). However, it is not known if low-level macrolide affects the expression of MexAB-OprM and, if so, how it influences antibiotic susceptibility of the cells. Thus, we investigated this issue in this study.

Relevant properties of the P. aeruginosa strains used are as follows: PAO4290 is a laboratory prototype strain (32); TNP090 is a derivative of PAO4290 that carries a chromosomal mexB::xylE fusion construct producing catechol 2,3-dioxygenase (Cat-2,3-diO) in place of MexB (16); TNP091, TNP092, and TNP093 are the derivatives of TNP090, which lack lasI and rhlI and both lasI and rhlI, respectively (16). TNP030 carries a mutation in mexR, producing an elevated level of MexAB-OprM (25). TNP077 lacks chromosomal mexAB-oprM (17). The amount of MexAB-OprM expressed was quantified as the reporter enzyme activity of Cat-2,3-diO. An overnight culture of the TNP090 strain (las+rhl+) was diluted 100,000-fold (or 10,000-fold) with fresh Luria-Bertani broth containing 1 μg/ml of azithromycin (AZM) or without the drug, adjusting the A600 to 3 × 10−5 (or 3 × 10−4). The flasks were rotated at 200 rpm at 37°C for the desired period of time. Cells were harvested by centrifugation at 5,000 × g for 15 min. Cat-2,3-diO activity was determined, as reported earlier (28), in the cell extracts, prepared by passage through a French pressure cell at 130 MPa three times and obtaining the supernatant from centrifugation at 13,000 × g for 20 min. One unit was defined as 1 nmol of substrate hydrolysis per min per mg of protein. Macrolide antibiotics did not interfere with the Cat-2,3-diO assay in the concentration range used. MICs of antibiotics were determined by the agar dilution method using Mueller-Hinton agar in the presence and absence of 1.0 μg/ml of AZM, which is 1/6.25 the MIC of AZM (MIC/6.25), in the respective strains. The cell number was adjusted to either 5 × 103 cells or 150 CFU/5 μl/spot.

TNP090 carrying mexB::xylE showed a low-level MIC of AZM at 6.25 μg/ml, due to impaired MexAB-OprM; otherwise, the level was 100 μg/ml. Thus, most experiments were conducted in the presence and absence of MIC/6.25 (1.0 μg/ml) of AZM, as determined by the agar dilution method with 5 × 103 cells. Overnight precultures grown without AZM expressed 95.2 and 82.1 units of Cat-2,3-diO (Fig. 1). These precultures were diluted with a 100,000-fold volume of fresh medium (calculated by an A600 of 3 × 10−5) to minimize the carryover of MexAB-OprM-positive cells, and the cells were grown for 4.5 h for drug-free culture and 5.5 h for AZM-containing culture to reach an A600 of 0.025. Cat-2,3-diO activity was 44.3 and 30.9 units for cultures in the presence and absence of AZM, respectively. The enzyme activity in cells without drug was 66.5, 167.0, and 179.6 units at 4.5 plus 2 h, plus 4 h, and plus 6 h, respectively. The results clearly showed that the MexAB-OprM transcriptional level increased in a cell density-dependent manner. Production of Cat-2,3-diO in the presence of 1.0 μg/ml of AZM at 5.5 h plus 2 h, plus 4 h, and plus 6 h of culture was −30.9, −73, −70.2, and −63%, respectively, relative to the values in the drug-free culture. These results clearly demonstrated that a MIC/6.25 of AZM suppressed the production of the MexAB-OprM pump. Similar experiments were conducted using the TNP091, TNP092, and TNP093 cells lacking lasI and rhlI and both lasI and rhlI, respectively, at 9 h of culture, which is equivalent to an A600 of ∼1.5 or early stationary growth phase, and their Cat-2,3-diO activity levels appeared to be 99, 90, and 100%, respectively, of those in TNP090 (data not shown), suggesting that macrolide-mediated suppression of MexAB-OprM expression is unlikely to rely on the LasI and LasR circuits.

Since the sub-MIC level of AZM caused low-level expression of MexAB-OprM, it is conceivable that the cells grown in the presence of low-level AZM became more susceptible to the pump-substrate antibiotics than the cells grown in the AZM-free culture. Thus, we determined the MIC of several antibiotics in the presence of 16 μg/ml (MIC/6.25) of AZM in the PAO4290 cells producing the wild-type level of MexAB-OprM. The MICs of chloramphenicol, aztreonam, tetracycline, carbenicillin, and novobiocin in plates containing 16 μg/ml of AZM were 1/4, 1/2, 1/4, 1/4, and 1/4, respectively, of that in the drug-free culture (Table 1). The MIC of imipenem, which is not the substrate of the MexAB-OprM efflux pump, appeared the same in the presence and absence of AZM, as expected. The MICs of ceftazidime and ofloxacin, which are poor substrates for the MexAB-OprM pump (32), were indistinguishable in the presence and absence of AZM. AZM exerted no significant effect on the MICs of antibiotics in the mutant lacking MexAB-OprM, TNP077, as expected. The MICs of antibiotics in the mexR mutant TNP030, which overproduces MexAB-OprM, were identical in cultures grown in the presence and absence of AZM. The reason for this is not known.

The effects of several antibiotics at MIC/50 through MIC/6.25 was examined. The Cat-2,3-diO activities in the presence of 0.125, 0.25, 0.5, and 1 μg/ml of AZM were lowered retrogressively to 85, 78, 65, and 37% compared with that of the respective drug-free cultures (Fig. 2). The results demonstrated that AZM suppressed the production of MexAB-OprM in a concentration-dependent manner. Analogous experiments were carried out using the 14-membered macrolides erythromycin and clarithromycin and confirmed that these macrolides exerted an effect similar to that of AZM. A 16-membered macrolide, josamycin, showed only a marginal effect. Tetracycline at 0.016, 0.03, 0.06, and 0.125 μg/ml led to Cat-2,3-diO production at levels of 103, 94, 69 and 51%, respectively. On the other hand, streptomycin and chloramphenicol showed only a marginal effect on the Cat-2,3-diO production. Imipenem exerted no detectable effect.

An unanswered question is whether macrolide-mediated suppression of the MexAB-OprM expression is linked to the Q-S system(s). This study revealed that at least the Las and Rhl systems are unlikely to be involved in the macrolide-mediated suppression of MexAB-OprM. On the other hand, the suppression was canceled in the mexR mutant. Our earlier study reported that the expression of mexAB-oprM was upregulated by the Q-S mediator C4-homoserine lactone (26). Therefore, the macrolide-mediated downregulation of MexAB-OprM expression is different from the Rhl-mediated upregulation; yet, the possible involvement of the Q-S system could not be entirely ruled out because uncharacterized Q-S systems, such as quinolone quorum sensing, may exist (4, 23). Though low-level macrolide antibiotics might have directly inhibited protein synthesis and consequently lowered the production of MexAB-OprM, this action is less likely because chloramphenicol and streptomycin, both acting on protein synthesis machinery, exerted only a little effect. Further studies may be needed to clarify this issue.

FIG. 1.
  • Open in new tab
  • Download powerpoint
FIG. 1.

Effect of sub-MIC level of azithromycin on the growth-phase-dependent expression of MexAB-OprM. An overnight culture of the TNP090 (las+rhl+) mutant was diluted 100,000-fold as mentioned in the text, and the flasks were rotated at 200 rpm at 37°C for the desired period of time. Cells in the drug-free culture were harvested as the A600 reached ∼0.03 in about 4.5 h and at 5.5 h for the 1-μg/ml AZM culture. Similarly, the culture was harvested at 4.5 (or 5.5) plus 2 h, plus 4 h, and plus 6 h. The amount of MexAB-OprM expressed was quantified as the activity of the reporter enzyme, Cat-2,3-diO. The values shown are representative results of repeated experiments. Gray columns, Cat-2,3-diO in the drug-free culture; dark-gray columns, Cat-2,3-diO in the 1-μg/ml AZM culture; filled triangle, A6001 cm of the drug-free culture; filled circle, A6001 cm of the 1-μg/ml AZM culture.

FIG. 2.
  • Open in new tab
  • Download powerpoint
FIG. 2.

Effect of various antibiotics at sub-MIC levels on the expression of MexAB-OprM. Precultures of the TNP090 cells grown overnight were diluted 10,000-fold with 300 ml of fresh medium, and the flasks were rotated at 200 rpm for 9 h (until A600 of ∼1.5, which is early stationary growth phase) at 37°C. Preparation of cell extracts and the assay for the Cat-2,3-diO activity were similar to that described in the text. The Cat-2,3-diO activity was expressed relative to that in the drug-free culture. Antibiotic concentration was expressed relative to the MIC of the respective antibiotics in TNP090. The cells grew poorly in the presence of MIC/6.25 of tetracycline (TET). The values shown are representative results of repeated experiments. AZM, 6.25 μg/ml; CLR, clarithromycin (12.5 μg/ml); TET, 0.78 μg/ml; CHL, chloramphenicol (1.56 μg/ml); ERY, erythromycin (12.5 μg/ml); JM, josamycin (200 μg/ml); IPM, imipenem (0.78 μg/ml); STR, streptomycin (0.78 μg/ml).

View this table:
  • View inline
  • View popup
TABLE 1.

MICs of antibiotics in the presence and absence of AZMa

ACKNOWLEDGMENTS

This study was supported by grants from the Ministry of Education and Science, Japan.

FOOTNOTES

    • Received 19 April 2008.
    • Returned for modification 2 June 2008.
    • Accepted 25 July 2008.
  • Copyright © 2008 American Society for Microbiology

REFERENCES

  1. 1.↵
    Akama, H., M. Kanemaki, M. Yoshimura, T. Tsukihara, T. Kashiwagi, H. Yoneyama, S. Narita, A. Nakagawa, and T. Nakae. 2004. Crystal structure of the drug discharge outer membrane protein, OprM, of Pseudomonas aeruginosa. J. Biol. Chem.279:52816-52819.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    Akama, H., T. Matuura, S. Kashiwagi, H. Yoneyama, S. Narita, T. Tsukihara, A. Nakagawa, and T. Nakae. 2004. Crystal structure of the membrane fusion protein, MexA, of the multidrug transporter in Pseudomonas aeruginosa. J. Biol. Chem.279:25939-25942.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    Brooun, A., S. Liu, and K. Lewis. 2000. A dose-response study of antibiotic resistance in Pseudomonas aeruginosa biofilm. Antimicrob. Agents Chemother.44:640-646.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    Calfee, M.-W., J. P. Coleman, and E.-C. Pesci. 2001. Interference with Pseudomonas quinolone signal synthesis inhibits virulence factor expression by Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. USA98:11633-11637.
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    Daigle, D. M., L. Cao, S. Fraud, M. S. Wilke, A. Pacey, R. Klinoski, N. C. Strynadka, C. R. Dean, and K. Poole. 2007. Protein modulator of multidrug efflux gene expression in Pseudomonas aeruginosa. J. Bacteriol.189:5441-5451.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    Dinh, T., I. T. Paulsen, and M. H. Saier, Jr. 1994. A family of extracytoplasmic proteins that allow transport of large molecules across the outer membranes of gram-negative bacteria. J. Bacteriol.176:3825-3831.
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    Eda, S., H. Maseda, and T. Nakae. 2003. An elegant means of self-protection in Gram-negative bacteria by recognizing and extruding xenobiotics from the periplasmic space. J. Biol. Chem.278:2085-2088.
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    Equi, A., I. M. Balfour-Lynn, A. Bush, and M. Rosenthal. 2002. Long term azithromycin in children with cystic fibrosis: a randomised placebo-controlled crossover trial. Lancet360:978-984.
    OpenUrlCrossRefPubMedWeb of Science
  9. 9.↵
    Favre-Bonte, S., T. Kohler, and C. van Delden. 2003. Biofilm formation by Pseudomonas aeruginosa: role of the C4-HSL cell-to-cell signal and inhibition by azithromycin. J. Antimicrob. Chemother.52:598-604.
    OpenUrlCrossRefPubMedWeb of Science
  10. 10.↵
    Guan, L., M. Ehrmann, H. Yoneyama, and T. Nakae. 1999. Membrane topology of the xenobiotic-exporting subunit, MexB, of the MexA,B-OprM extrusion pump in Pseudomonas aeruginosa. J. Biol. Chem.274:10517-10522.
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    Higgins, M. K., E. Bokma, E. Koronakis, C. Hughes, and V. Koronakis. 2004. Structure of the periplasmic component of a bacterial drug efflux pump. Proc. Natl. Acad. Sci. USA101:9994-9999.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    Howe, R. A., and R. C. Spencer. 1997. Macrolides for the treatment of Pseudomonas aeruginosa infections? J. Antimicrob. Chemother.40:153-155.
    OpenUrlCrossRefPubMedWeb of Science
  13. 13.↵
    Jaffe, A., J. Francis, M. Rosenthal, and A. Bush. 1998. Long-term azithromycin may improve lung function in children with cystic fibrosis. Lancet351:420.
    OpenUrlCrossRefPubMedWeb of Science
  14. 14.
    Kudoh, S., H. Kimura, K. Uetake, et al. 1984. Clinical effect of low-dose long-term administration of macrolides on diffuse panbronchiolitis. Jpn. J. Thorac. Dis.22:254. (In Japanese.)
    OpenUrl
  15. 15.↵
    Kudoh, S., T. Uetake, K. Hagiwara, et al. 1987. Clinical effects of low-dose longterm erythromycin chemotherapy on diffuse panbronchiolitis. Nippon Kyobu Shikkan Gakkai Zasshi25:632-642. (In Japanese.)
    OpenUrlPubMed
  16. 16.↵
    Maseda, H., I. Sawada, K. Saito, H. Uchiyama, T. Nakae, and N. Nomura. 2004. Enhancement of the MexAB-OprM efflux pump expression by a quorum-sensing autoinducer and its cancellation by a regulator, MexT, of the MexEF-OprN efflux pump operon in Pseudomonas aeruginosa. Antimicrob. Agents Chemother.48:1320-1328.
    OpenUrlAbstract/FREE Full Text
  17. 17.↵
    Maseda, H., H. Yoneyama, and T. Nakae. 2000. Assignment of the substrate-selective subunits of the MexEF-OprN multidrug efflux pump of Pseudomonas aeruginosa. Antimicrob. Agents Chemother.44:658-664.
    OpenUrlAbstract/FREE Full Text
  18. 18.↵
    Murakami, S., R. Nakashima, E. Yamashita, T. Matsumoto, and A. Yamaguchi. 2006. Crystal structures of a multidrug transporter reveal a functionally rotating mechanism. Nature2006:173-179.
    OpenUrl
  19. 19.↵
    Nakae, T., E. Yoshihara, and H. Yoneyama. 1997. Multiantibiotic resistance caused by active drug extrusion in hospital pathogens. J. Infect. Chemother.3:173-183.
    OpenUrlCrossRef
  20. 20.↵
    Nikaido, H. 1996. Prevention of drug access to bacterial targets: permeability barriers and active efflux. Science264:221-229.
    OpenUrl
  21. 21.↵
    Nouwens, A. S., S. A. Beatson, C. B. Whitchurch, B. J. Walsh, H. P. Schweizer, J. S. Mattick, and S. J. Cordwell. 2003. Proteome analysis of extracellular proteins regulated by the las and rhl quorum sensing systems in Pseudomonas aeruginosa PAO1. Microbiology149:1311-1322.
    OpenUrlCrossRefPubMedWeb of Science
  22. 22.↵
    Pearson, J. P., C. van Delden, and B. H. Iglewski. 1999. Active efflux and diffusion are involved in transport of Pseudomonas aeruginosa cell-to-cell signal. J. Bacteriol.181:1203-1210.
    OpenUrlAbstract/FREE Full Text
  23. 23.↵
    Pesci, E. C., J. B. J. Milbank, J. P. Pearson, S. Mcknight, A. S. Kende, E. P. Greenberg, and B. H. Iglewski. 1999. Quinolone signaling in the cell-to-cell communication system of Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. USA96:11229-11234.
    OpenUrlAbstract/FREE Full Text
  24. 24.↵
    Poole, K. 2001. Multidrug efflux pumps and antimicrobial resistance in Pseudomonas aeruginosa and related organisms. J. Mol. Microbiol. Biotechnol.3:255-263.
    OpenUrlPubMedWeb of Science
  25. 25.↵
    Saito, K., H. Yoneyama, and T. Nakae. 1999. nalB-type mutations causing the overexpression of the MexAB-OprM efflux pump are located in the mexR gene of the Pseudomonas aeruginosa chromosome. FEMS Microbiol. Lett.179:67-72.
    OpenUrlCrossRefPubMedWeb of Science
  26. 26.↵
    Sawada, I., H. Maseda, T. Nakae, H. Uchiyama, and N. Nomura. 2004. A quorum-sensing autoinducer enhances the mexAB-oprM efflux-pump expression without the MexR-mediated regulation in Pseudomonas aeruginosa. Microbiol. Immunol.48:435-439.
    OpenUrlCrossRefPubMedWeb of Science
  27. 27.↵
    Schuster, M., C. P. Lostroh, T. Ogi, and E. P. Greenberg. 2003. Identification, timing, and signal specificity of Pseudomonas aeruginosa quorum-controlled genes: a transcriptome analysis. J. Bacteriol.185:2066-2079.
    OpenUrlAbstract/FREE Full Text
  28. 28.↵
    Schweizer, H. P. 1993. Two plasmids, X1918 and Z1918, for easy recovery of the xelE and lacZ reporter genes. Gene134:89-91.
    OpenUrlCrossRefPubMedWeb of Science
  29. 29.↵
    Sofer, D., N. Gilboa-Garber, A. Belz, and N. C. Garber. 1999. Subinhibitory erythromycin represses production of Pseudomonas aeruginosa lectins, autoinducer and virulence factors. Chemotherapy45:335-341.
    OpenUrlCrossRefPubMedWeb of Science
  30. 30.↵
    Tateda, K., T. J. Standiford, J. C. Pechere, and K. Yamaguchi. 2004. Regulatory effects of macrolides on bacterial virulence: potential role as quorum-sensing inhibitors. Curr. Pharm. Design.10:3055-3065.
    OpenUrlCrossRefPubMedWeb of Science
  31. 31.↵
    Whitehead, N. A., A. M. Bernard, H. Slater, N. J. Simpson, and G. P. Salmond. 2001. Quorum-sensing in Gram-negative bacteria. FEMS Microbiol. Lett.25:365-404.
    OpenUrl
  32. 32.↵
    Yoneyama, H., A. Ocaktan, M. Tsuda, and T. Nakae. 1997. The role of mex-gene products in antibiotic extrusion in Pseudomonas aeruginosa. Biochem. Biophys. Res. Commun.233:611-618.
    OpenUrlCrossRefPubMed
View Abstract
PreviousNext
Back to top
Download PDF
Citation Tools
Macrolide Antibiotic-Mediated Downregulation of MexAB-OprM Efflux Pump Expression in Pseudomonas aeruginosa
Makoto Sugimura, Hideaki Maseda, Hideaki Hanaki, Taiji Nakae
Antimicrobial Agents and Chemotherapy Oct 2008, 52 (11) 4141-4144; DOI: 10.1128/AAC.00511-08

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Antimicrobial Agents and Chemotherapy article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Macrolide Antibiotic-Mediated Downregulation of MexAB-OprM Efflux Pump Expression in Pseudomonas aeruginosa
(Your Name) has forwarded a page to you from Antimicrobial Agents and Chemotherapy
(Your Name) thought you would be interested in this article in Antimicrobial Agents and Chemotherapy.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Macrolide Antibiotic-Mediated Downregulation of MexAB-OprM Efflux Pump Expression in Pseudomonas aeruginosa
Makoto Sugimura, Hideaki Maseda, Hideaki Hanaki, Taiji Nakae
Antimicrobial Agents and Chemotherapy Oct 2008, 52 (11) 4141-4144; DOI: 10.1128/AAC.00511-08
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Anti-Bacterial Agents
Bacterial Outer Membrane Proteins
macrolides
Membrane Transport Proteins
Pseudomonas aeruginosa

Related Articles

Cited By...

About

  • About AAC
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • AAC Podcast
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AACJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0066-4804; Online ISSN: 1098-6596